Fred Saad

3.6k total citations
15 papers, 333 citations indexed

About

Fred Saad is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Fred Saad has authored 15 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Fred Saad's work include Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (3 papers). Fred Saad is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Cancer, Lipids, and Metabolism (3 papers). Fred Saad collaborates with scholars based in Canada, United States and Italy. Fred Saad's co-authors include Srikala S. Sridhar, Robert Sabbagh, Michael McCormack, Pierre I. Karakiewicz, François Péloquin, Jean‐Paul Perreault, Paul Perrotte, Celestia S. Higano, Tom Corbett and E.M. Horwitz and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

Fred Saad

9 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Saad Canada 5 248 84 74 67 51 15 333
Taketoshi Nara Japan 10 151 0.6× 64 0.8× 83 1.1× 78 1.2× 28 0.5× 42 277
Fucai Tang China 11 205 0.8× 96 1.1× 169 2.3× 54 0.8× 27 0.5× 40 367
Arturo Mendoza-Valdés Mexico 4 170 0.7× 60 0.7× 80 1.1× 67 1.0× 13 0.3× 9 307
Shuai Hu China 10 123 0.5× 46 0.5× 63 0.9× 81 1.2× 15 0.3× 18 310
François‐Xavier Nouhaud France 11 282 1.1× 51 0.6× 81 1.1× 36 0.5× 15 0.3× 36 362
Takuto Hara Japan 10 242 1.0× 69 0.8× 86 1.2× 105 1.6× 12 0.2× 76 354
Maximilian Pallauf Austria 12 245 1.0× 30 0.4× 99 1.3× 61 0.9× 14 0.3× 57 447
Charlien Berghen Belgium 11 279 1.1× 56 0.7× 23 0.3× 46 0.7× 9 0.2× 39 366
Hayriye Tatlı Doğan Türkiye 11 81 0.3× 88 1.0× 101 1.4× 107 1.6× 26 0.5× 41 338
Haowen Jiang China 12 220 0.9× 57 0.7× 55 0.7× 92 1.4× 34 0.7× 20 303

Countries citing papers authored by Fred Saad

Since Specialization
Citations

This map shows the geographic impact of Fred Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Saad more than expected).

Fields of papers citing papers by Fred Saad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Saad. The network helps show where Fred Saad may publish in the future.

Co-authorship network of co-authors of Fred Saad

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Saad. A scholar is included among the top collaborators of Fred Saad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Saad. Fred Saad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Falkenbach, Fabian, Natali Rodriguez Peñaranda, Mattia Longoni, et al.. (2025). The Effect of Chronic Kidney Disease on Adverse In‐Hospital Outcomes at Radical Prostatectomy. International Journal of Urology. 32(6). 710–717.
2.
Saad, Fred, Teresa Alonso‐Gordoa, Philippe Barthélémy, et al.. (2025). Circulating tumor DNA levels and related kinetics as prognostic biomarkers for clinical outcomes in mCRPC: A post hoc analysis of CM 7DX.. Journal of Clinical Oncology. 43(5_suppl). 252–252. 1 indexed citations
3.
4.
5.
Tolcher, Anthony W., Tanya B. Dorff, Sumiko Okubo, et al.. (2025). Phase 1, open-label, first-in-human study of ABBV-969, a dual variable antibody-drug conjugate, in patients with metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. 43(16_suppl).
6.
Morgans, Alicia K., Mindaugas Jievaltas, David Olmos, et al.. (2025). Health-related quality of life (HRQoL) outcomes with darolutamide in the phase 3 ARANOTE trial.. Journal of Clinical Oncology. 43(16_suppl). 5004–5004.
7.
Siech, Carolin, Mario de Angelis, Francesco Di Bello, et al.. (2024). Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival. Annals of Surgical Oncology. 31(13). 8993–9001.
8.
Fleshner, Neil, Rui Bernardino, Katherine Lajkosz, et al.. (2024). A randomized, double-blind, placebo-controlled trial of metformin in reducing progression among men on expectant management for low-risk prostate cancer: The MAST (Metformin Active Surveillance Trial) study.. Journal of Clinical Oncology. 42(17_suppl). LBA5002–LBA5002. 7 indexed citations
9.
Incesu, Reha‐Baris, Simone Morra, Andrea Baudo, et al.. (2024). Primary tumor ablation in metastatic renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 43(5). 332.e11–332.e18.
10.
Angelis, Mario de, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.. (2024). ASO Visual Abstract: Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival. Annals of Surgical Oncology. 32(1). 623–624. 1 indexed citations
11.
Bello, Francesco Di, Letizia Maria Ippolita Jannello, Andrea Baudo, et al.. (2024). Life Expectancy in High‐Grade Incidental Prostate Cancer Patients Versus Population‐Based Controls According to Treatment Type. The Prostate. 85(2). 191–197. 4 indexed citations
12.
Leyh‐Bannurah, Sami‐Ramzi, Véronique Ouellet, Zhe Tian, et al.. (2020). MP19-20 STATE-OF-THE-ART WEAKLY SUPERVISED AUTOMATED CLASSIFICATION OF PROSTATE CANCER TISSUE MICROARRAYS VIA DEEP LEARNING: CAN SUFFICIENT ACCURACY BE ACHIEVED WITHOUT MANUAL PATCH LEVEL ANNOTATION?. The Journal of Urology. 203(Supplement 4). 2 indexed citations
13.
Crook, Juanita, Chris J. O’Callaghan, Kevin Ding, et al.. (2011). A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013).. Journal of Clinical Oncology. 29(15_suppl). 4514–4514. 33 indexed citations
14.
Sridhar, Srikala S., et al.. (2009). Castration-resistant Prostate Cancer: From New Pathophysiology to New Treatment Targets. European Urology. 56(4). 594–605. 207 indexed citations
15.
Sabbagh, Robert, Michael McCormack, François Péloquin, et al.. (2004). A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy.. PubMed. 11(2). 2216–9. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Taketoshi Nara Breakdown of academic impact, for papers by Fucai Tang Breakdown of academic impact, for papers by Arturo Mendoza-Valdés Breakdown of academic impact, for papers by Shuai Hu Breakdown of academic impact, for papers by François‐Xavier Nouhaud Breakdown of academic impact, for papers by Takuto Hara Breakdown of academic impact, for papers by Maximilian Pallauf Breakdown of academic impact, for papers by Charlien Berghen Breakdown of academic impact, for papers by Hayriye Tatlı Doğan Breakdown of academic impact, for papers by Haowen Jiang
Rankless by CCL
2026